Variant report
Variant | nsv1020966 |
---|---|
Chromosome Location | chr9:11512184-11557454 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565954752 | chr9:11521840-11521841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528662154 | chr9:11521851-11521852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551820140 | chr9:11521882-11521883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142247167 | chr9:11521905-11521906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537095064 | chr9:11521968-11521969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186865397 | chr9:11521975-11521976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58627529 | chr9:11521977-11521978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567627003 | chr9:11522000-11522001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536761217 | chr9:11522008-11522009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4740502 | chr9:11522013-11522014 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs572176977 | chr9:11522022-11522023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554530728 | chr9:11522027-11522028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73403589 | chr9:11522042-11522043 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs374335716 | chr9:11522045-11522046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189189174 | chr9:11522178-11522179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577867226 | chr9:11522179-11522180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543273016 | chr9:11522185-11522186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562960065 | chr9:11522190-11522191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76123289 | chr9:11534680-11534681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547402420 | chr9:11534709-11534710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150394292 | chr9:11534751-11534752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570751926 | chr9:11534765-11534766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188279982 | chr9:11534767-11534768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560221795 | chr9:11534772-11534773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs138340918 | chr9:11534782-11534783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs552030053 | chr9:11534792-11534793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144543619 | chr9:11534795-11534796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73644033 | chr9:11534808-11534809 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs370671638 | chr9:11534827-11534828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374304500 | chr9:11534829-11534830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531265259 | chr9:11534845-11534846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143092802 | chr9:11534874-11534875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568284652 | chr9:11534890-11534891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73405409 | chr9:11534927-11534928 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs72700206 | chr9:11535004-11535005 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs570551211 | chr9:11535009-11535010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563121093 | chr9:11535010-11535011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs117783197 | chr9:11535032-11535033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556237551 | chr9:11535034-11535035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576491260 | chr9:11535035-11535036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530554760 | chr9:11535054-11535055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138984908 | chr9:11535068-11535069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192565038 | chr9:11535167-11535168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574665098 | chr9:11535169-11535170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540568695 | chr9:11535208-11535209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142140552 | chr9:11535246-11535247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183737270 | chr9:11535256-11535257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188267652 | chr9:11535271-11535272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546741989 | chr9:11535323-11535324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs199946242 | chr9:11535324-11535325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11521800-11522200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr9:11534600-11535000 | Enhancers | Fetal Brain Male | brain |
3 | chr9:11535000-11538200 | Weak transcription | Fetal Brain Male | brain |
4 | chr9:11537800-11538800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:11538200-11538600 | Enhancers | Fetal Brain Male | brain |
6 | chr9:11538600-11545600 | Weak transcription | Fetal Brain Male | brain |
7 | chr9:11545600-11547000 | Enhancers | Fetal Brain Male | brain |
8 | chr9:11545800-11546600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr9:11546000-11546800 | Enhancers | Fetal Brain Female | brain |
10 | chr9:11546400-11546800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr9:11546600-11547600 | Enhancers | Brain Germinal Matrix | brain |
12 | chr9:11549200-11550800 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr9:11549200-11554400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr9:11553200-11553600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr9:11553200-11553600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr9:11553400-11553800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |